000			03798cam a2200385Ii 4500
999			_c96754 _d96754 _x1
001			96754
003			ES-MaUEC
005			20230102112809.0
006			m o d
007			cr cnu---unuuu
008			171212s2017 sz ob 001 0 eng d
020			_a3319636332 _q(electronic bk.)
020			_a9783319636337 _q(electronic bk.)
020			_z9783319636320 _q(print)
040			_aN$T _beng _erda _epn _cN$T _dGW5XE _dN$T _dEBLCP _dOCLCF _dUAB _dDKU _dES-MaUEC _bspa
050		4	_aR857.N34 _b2017 EB
245	0	0	_aAdvances in personalized nanotherapeutics _cAjeet Kaushik, Rahul Dev Jayant, Madhavan Nair, editors.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
500			_a
504			_aIncluye referencias bibliográficas e índice
520	3		_aHealth agencies have declared personalized nanomedicine as an important area to investigate novel therapies to combat against targeted diseases with no-side effects. The disease profile varies from patient-to-patient and standard therapies sometime are unsuitable for complete cure. This raises the demand of nanomedicine development. The tunable therapeutic salient features of nanomedicine including site-specific delivery and controlled release of a specific drug according to patient requirement make nanomedicine very special. Such of human compatible personalization is very useful in diseases management required to optimize a therapy for health care. Knowing the potentials of the nanomedicines, significant efforts are being to design and develop nano-enabled therapeutic strategies to cure and monitor diseases contributing to personalized health care. As per state-of-the-art, various approaches have been optimized resulting in development of pharmacologically relevant personalized nanomedicine to combat against diseases with improved efficacy and no adverse effects. In this book, we described the fundamentals nanomedicine, nanotechnology for nanomedicine development, approach of personalized nanomedicine, potential novel nano-carriers for site-specific drug delivery, role of nano-bio-technology for efficient therapeutics, nano-pharmacology, targeted CNS drug delivery, stimuli- responsive drug release, aspects of bioinformatics for diseases management, miniaturized bio-sensing systems for diseases detection with monitoring, and nano-bio-technology for diseases management. The challenges in personalized nano-therapeutics development, possible vision to overcome challenges, and future prospects to promote therapies for clinical application are also discussed in this book. We believe that present book would serve as a platform for new scholars of academia and industries to understand state-of-the-art of nano-bio-technology for therapeutics to plan future research to develop effective personalized nanomedicine against targeted diseases. Our book is a call for experts to explore multidisciplinary research towards developing novel personalized nanomedicines to combat against targeted diseases to personalized health care.
588	0		_aOnline resource; title from PDF title page (EBSCO, viewed December 20, 2017)
988			_aEBOOK, EBSPRINGER_2017
650		7	_aNanomedicina _2embne _9445593
700	1		_aJayant, Rahul Dev, _eeditor literario
700	1		_aKaushik, Ajeet Kumar, _eeditor literario
700	1		_aNair, Madhavan, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-63633-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI